Elevance Health, Inc. (ELV)

Elevance Health's stock price has trended down by 18.78% in the past six months and 19.47% over the past year, though it saw a 7.47% increase in the past month. In October 2025, Elevance Health reported strong Q3 financial results, surpassing earnings expectations, but the stock experienced a slight decline in pre-market trading. The company reaffirmed its full-year 2025 adjusted EPS guidance of approximately $30.00. Elevated medical costs, particularly in Medicare and Medicaid, impacted operating revenue. Molina Healthcare's weak Q3 outlook led to a decline in health insurer stocks, including Elevance Health. TD Cowen raised its price target for Elevance Health, while other analysts downgraded their ratings. Director Susan D. Devore acquired 1,200 shares, and the company disclosed a quarterly dividend of $1.71.

Elevance Health experiences demand seasonality in its Medicare business due to changes in Part D benefits. The company anticipates higher utilization of benefits in the fourth quarter as members prepare for changes to ACA plans. The expiration of additional premium tax credits in 2026 adds uncertainty to individual plan enrollments.

Elevance Health, Inc. is a healthcare technology company providing digital solutions to improve patient outcomes and reduce administrative burdens. It operates in the Accident & Health Insurance industry, offering health plans and services to various groups, including individuals, employers, and Medicare/Medicaid members. Its offerings include commercial, Medicare, and Medicaid plans, pharmacy benefit management, behavioral health services, care management, and specialty products.

Elevance Health has a significant geographic footprint across the United States. In 2026, the company plans to offer individual health plans in 18 states and 1,000 counties, expanding from 17 states and 1,005 counties in the previous year. This includes Anthem Blue Cross and Blue Shield plans in 14 states and Wellpoint plans in four states, with Wellpoint adding Washington state as a new market for 2026. The company serves millions of members nationwide through its various brands.

Elevance Health, formerly Anthem Inc., rebranded in 2022 to reflect its comprehensive approach to health. The company focuses on improving the health of humanity and serving people across their entire health journey with an integrated whole-health approach. Elevance Health has been recognized as one of "America's Greenest Companies 2026" and highlights strategic partnerships and product innovations as key growth drivers.

Institutional shareholders hold a significant majority (89.24%) of Elevance Health's stock, while insider shareholders hold 0.29%. OVERSEA CHINESE BANKING Corp Ltd increased its stake by 114.6% in Q2 2025, and Artisan Mid Cap Value Fund initiated a new position in Q3 2025.